The medical aesthetics market is projected to be worth USD 34,124.0 million by 2030, growing at a CAGR of 12.4%. This would be a result of the increasing development of technologically enhanced and easy-to-use products and the mounting need for aesthetic treatments among people.
Furthermore, the acceptance of non-invasive and minimally invasive aesthetic methods is increasing worldwide due to the loose facial skin, specifically around the jowls, cheeks, and eyes, and dry skin for others, which are some of the significant changes that typically happen when an individual ages. In addition, the need for aesthetic equipment is growing, because of the surging acceptance of cosmetic methods among common people, to look better.
North America held the largest revenue share in recent years and the continent is also projected to be in the leading position to reach USD 15 billion by 2030. This can be credited to innovation in cosmetic practices as a huge number of future key players and established players either have headquarters or have a significant existence in the region.
Get the sample copy of this report:Â https://www.psmarketresearch.com/market-analysis/medical-aesthetics-market/report-sample
Moreover, the growing investment in the healthcare sector, the governments’ supportive initiatives for inviting foreign investments, and the mounting R&D development via enhanced technologies are contributing to the growth of the regional market.
The APAC medical aesthetics market is projected to grow at a significant rate in the years to come. Developing countries in the region are showing a significant surge in the use of cosmetic treatments, mainly due to the reasons like increasing per capita income of middle-class people, the aging population, the growing awareness about skin problems, and the snowballing number of medical tourists in the region choosing for cosmetic treatments.
In recent years, the injectables category had the largest revenue share of over 40%, this can be ascribed to growing sales of injectables, including dermal fillers, botulinum toxin, and neurotoxins. In addition, the need for injectables is growing because of several factors like short procedure time, minimal scarring, instant result, cost-efficiency of the products, and minimally invasive.
The beauty clinics category holds the largest revenue share of over 50%, mainly because of the increasing per-capita of many countries, and also the snowballing number of beauty centers throughout the world. Such clinics come with several aesthetic treatments, including wrinkle treatment, body enhancement, augmentation, and scar removal. This is why the demand for dermal fillers and neurotoxins in beauty clinics and centers is increasing.
Hence, the Increasing development of technologically enhanced and easy-to-use products and the mounting need for aesthetic treatments among people are the major factors contributing to the growth of the medical aesthetics market.